Cysteine protease inhibitor-2

CAS No. 612048-23-4

Cysteine protease inhibitor-2( —— )

Catalog No. M24611 CAS No. 612048-23-4

Cysteine protease inhibitor 2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 In Stock
50MG 1782 In Stock
100MG 2250 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cysteine protease inhibitor-2
  • Note
    Research use only, not for human use.
  • Brief Description
    Cysteine protease inhibitor 2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
  • Description
    Cysteine protease inhibitor 2 is a cysteine protease inhibitor extracted from patent US20070032499A1, compound 12. Cysteine protease inhibitor 2 inhibited DCT116 and PC3 cells with GI50 values of 6.5 μM and 4.4 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Cysteine Protease
  • Recptor
    Cysteine protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    612048-23-4
  • Formula Weight
    247.21
  • Molecular Formula
    C13H5N5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N#CC1=C(C#N)N=C2C(/C(C3=C2C=CC=C3)=N/O)=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Philippe Guedat, et al. Novel cysteine protease inhibitors and their therapeutic applications. US20070032499A1.
molnova catalog
related products
  • Liraglutide

    Liraglutide is a long-acting GLP-1 receptor agonist.

  • Aurantiamide acetate

    Aurantiamide acetate was isolated from the fermentation broth of Aspergillus penicilloides for the first time. Aurantiamide acetate is a selective and orally active cathepsin inhibitor. Aurantiamide acetate has anti-inflammatory activities and can be used for the study of inflammatory diseases.

  • Cathepsin X-IN-1

    Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor (IC50 = 7.13 μM) that reduces PC-3 cell migration with low cytotoxicity .